caffeic acid phenethyl ester has been researched along with ethyl coumarate in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (ethyl coumarate) | Trials (ethyl coumarate) | Recent Studies (post-2010) (ethyl coumarate) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 8 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, F; Mohamed, T; Rao, PPN; Remião, F; Shakeri, A; Silva, T; Soares da Silva, P | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and ethyl coumarate
| Article | Year |
|---|---|
Repurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6.
Topics: Caffeic Acids; Catechols; Chelating Agents; Copper; Drug Design; Nitro Compounds; Peptides; Phenylethyl Alcohol; Polyphenols; Protein Aggregation, Pathological; Small Molecule Libraries; tau Proteins; Tauopathies | 2019 |